The Regional Cancer Center at Wellington
has added the newest and most
sophisticated radiation treatment system
available today to their arsenal of radiation
therapy technologies, called Novalis Shaped
Beam Surgery from BrainLAB. The Regional
Cancer Center is the only treatment center in
Southeast Florida and one of only 48 treatment
centers across the country to offer this advanced
radiation technology.
What It's Used For
Novalis® Shaped Beam Surgery by BrainLAB is
a dedicated system for noninvasive stereotactic
radiosurgery and radiotherapy. First implemented
for the treatment of brain tumors or lesions,
where pinpoint precision is required, radiation
oncologists are now taking advantage of the
accuracy of Novalis to treat other areas of
the body and improve the range of a patient's
treatment options. Novalis can be used to treat:
- Cancers or benign lesions that have started in the brain or spread to the brain.
- Arteriovenous malformations (a type of vascular disorder) of the brain.
- Functional brain disorders (e.g. trigeminal neuralgia/tic douloureux).
- Relatively small tumors in other areas of the body, such as the head and neck, prostate, liver, spine or certain other areas near bony landmarks or where metallic markers can be surgically implanted.
- Tumors located so close to sensitive normal structures that it would be dangerous to treat the tumor with standard radiation techniques, such as tumors close to the spinal cord. This is exceptionally beneficial in situations where the region has been previously irradiated.
Treatment Options
With this innovative treatment, high-energy
radiation beams damage tumor cells and cause
them to die. Novalis Shaped Beam Surgery is
either applied in a single session with a high dose
of radiation, called stereotactic radiosurgery, or
in a series of treatments over a period of time,
called fractionated stereotactic radiotherapy.
Fractionated stereotactic radiotherapy involves
similar doses of radiation to stereotactic
radiosurgery, but the radiation is delivered
in smaller amounts. The radiation oncologist
prescribes the most-appropriate technique for
the patient based on the size and location of the
tumor or lesion.
Novalis® frameless X-ray positioning according to a patient's anatomy
PHOTO COURTESY OF BRAINLAB AG.
How It Works
With Novalis, micro-multileaf collimation shapes
the radiation beams to precisely match the
contour of the tumor or lesion. During treatment,
Novalis steadily moves around the patient's body
so that the radiation penetrates the target from
different angles.
Computer software calculates the angles of the
beams that will best treat the targeted area. While
that area receives the full dose, the surrounding
healthy tissue only receives a small percentage of the radiation dose. This
reduces potential damage to delicate structures, such as the brain stem and
spinal cord.
Novalis also combines multiple advanced technologies for image
guidance. Patients are positioned using X-rays and infrared three-dimensional
real-time imaging. The X-ray system can use both bony
landmarks and implanted metallic markers. The Novalis computer then
analyzes these images to move the patient to the precisely intended position.
"This technology is one of the fi rst and is the only one available that
incorporates image guidance and precise shaping of radiation beams to
conform to the tumor, using X-rays and an infrared localization positioning
system," says Kishore K. Dass, MD, Chief Radiation Oncologist and
Medical Director of The Regional Cancer Center. "We can now use image
guidance to evaluate the movement of the lung or liver with respiration, and
adjust the radiation beam to the movement of the tumor."
Novalis is noninvasive, with the exception of the small radio-opaque
markers the surgeon implants. Treatment is virtually painless and usually
performed on an outpatient basis.
For More Information
At The Regional Cancer Center at Wellington, board-certifi ed radiation
oncologists and experienced treatment teams provide comprehensive
radiation therapy and follow-up care to thousands of patients each year.
For more information about this exciting technology, please call The
Regional Cancer Center at 561-793-6500.
Kishore K. Dass, MD, is a board-certified radiation oncologist and Medical Director of The Regional Cancer Center. Dr. Dass is a graduate of the Loyola University Chicago Stritch School of Medicine and an alumnus of the Cleveland Clinic Foundation, Cleveland, Ohio, where he was instrumental in the development of stereotactic radiosurgery.